Antiviral prophylaxis for the prevention of chronic hepatitis C virus in patients undergoing liver transplantation-Reference-Cited by-同舟云学术

Antiviral prophylaxis for the prevention of chronic hepatitis C virus in patients undergoing liver transplantation

Published:2013-12-02 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Gurusamy Kurinchi Selvan¹,Tsochatzis Emmanuel²,Toon Clare D³,Davidson Brian R¹,Burroughs Andrew K⁴

Affiliation:

1. Royal Free Campus, UCL Medical School; Department of Surgery; Royal Free Hospital, Rowland Hill Street London UK NW3 2PF

2. Royal Free Hampstead NHS Foundation Trust and UCL Institute of Liver and Digestive Health; Sheila Sherlock Liver Centre; Pond Street Hampstead London UK NW3 2QG

3. West Sussex County Council; Public Health; 1st Floor, The Grange Tower Street Chichester West Sussex UK PO19 1QT

4. Royal Free Hampstead NHS Foundation Trust; Sheila Sherlock Liver Centre; Pond Street Hampstead London UK NW3 2QG

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD006573.pub3/fullpdf

Reference89 articles.

1. Belli LS Alberti AB Rondinara GF de Carlis L Corti A Mazza E Early ribavirin treatment and avoidance of corticosteroids in hepatitis C virus (HCV)-positive liver transplant recipients: interim report of a prospective randomized trial Transplantation Proceedings 2001 1353 4

2. Peginterferon alfa-2a for hepatitis C after liver transplantation: two randomized, controlled trials (vol 41, pg 289, 2004);Alpert;Hepatology,2005

3. Peginterferon alfa-2a for hepatitis C after liver transplantation: two randomized, controlled trials;Chalasani;Hepatology,2005

4. 40 KDA peginterferon alfa-2a (PEGASYS) as a prophylaxis against hepatitis C infection recurrence after liver transplantation (LT): preliminary results of a randomized multicenter trial (abstract);Manzarbeitia;Hepatology,2001

5. Peginterferon alfa-2A (40 kd) (PEGASYS) in liver transplant recipients with established recurrent hepatitis C: interim results of an ongoing randomized multicenter trial [abstract];Vogel;Hepatology,2002

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revolution in the diagnosis and management of hepatitis C virus infection in current era;World Journal of Hepatology;2022-04-27

2. Liver Transplantation in Patients with Hepatitis C;Update on Hepatitis C;2017-10-04

3. Sofosbuvir and Ribavirin for 24 Weeks Is An Effective Treatment Option for Recurrent Hepatitis C Infection After Living Donor Liver Transplantation;Journal of Clinical and Experimental Hepatology;2017-09

4. Antiviral interventions for liver transplant patients with recurrent graft infection due to hepatitis C virus;Cochrane Database of Systematic Reviews;2013-12-04